The investment seeks capital appreciation... Show more
The Corgi Longevity Consumer ETF is an actively managed fund that does not passively track an index. Its adviser, Corgi Strategies, invests at least 80% of net assets in companies involved in consumer-oriented products and services believed to benefit from aging demographics and the spending preferences of older consumers, with an emphasis on extending "healthspan" — the period of life lived in good health — alongside lifestyle and services categories. The fund is non-diversified and carries a modest 0.35% expense ratio.
The portfolio exposure spans several distinct engines of the longevity economy. Healthcare is the largest sleeve, led by Eli Lilly, Medtronic (MDT), and Humana (HUM), capturing pharmaceutical innovation, medical devices, and managed care. Consumer discretionary holdings — including Booking Holdings (BKNG), Marriott (MAR), Royal Caribbean (RCL), and Delta Air Lines (DAL) — target the travel and leisure spending of affluent retirees. A real estate allocation centered on senior-housing REITs such as Welltower and Ventas provides demographic-driven demand for assisted-living and healthcare properties. Geographically, the fund is overwhelmingly U.S.-focused, limiting direct emerging-market exposure.
The macro outlook is a tug-of-war between powerful demographics and cyclical sensitivity. The aging of the U.S. population is a long-duration, largely non-discretionary demand driver: healthcare utilization, senior housing, and longevity-focused consumption tend to grow regardless of the business cycle. This provides a structural tailwind distinct from the broader equity market.
At the same time, the fund's sizable consumer-discretionary and real estate exposure makes it sensitive to interest rates and economic growth. Lower rates would generally support REIT valuations and travel spending, while a higher-for-longer rate environment could compress multiples and raise borrowing costs. Inflation trends also matter: persistent cost pressures in labor-intensive services such as healthcare and hospitality can compress margins. Because the ETF is concentrated in a handful of large-cap names and lacks meaningful emerging-market or defensive exposure, its macro outlook is tied closely to U.S. consumer health and the Fed's path.
For investors seeking a data-driven view of where an asset may be headed, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other instrument may trend bullish, bearish, or sideways over the coming week or month. The platform is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad universe of tradable assets, with searchable categories, historical context, and alert-oriented functionality. As you weigh the factors shaping this ETF forecast, consider exploring the Trend Prediction Engine to complement your own research.
The long-term outlook for this fund rests on the convergence of several durable themes. First, the secular aging of developed-world populations supports sustained demand for pharmaceuticals, medical devices, senior housing, and healthcare services. Second, the rise of GLP-1 therapies and personalized medicine could expand the healthspan economy well beyond weight management, reinforcing healthcare leadership in the portfolio. Third, wealthier, healthier retirees are increasingly allocating spending to experiences — travel, leisure, and premium hospitality — a structural shift in consumption patterns.
Structural risks warrant equal attention. Concentration in a few mega-cap holdings, sensitivity to interest-rate cycles, policy risk around Medicare and drug pricing, and limited diversification across geographies all temper the fund's resilience. Market structure changes, including the growth of active and thematic ETFs, may also intensify competition for flows. These long-term drivers and constraints, rather than short-term price moves, will ultimately shape the fund's trajectory within the evolving longevity-economy investment landscape.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YUNG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
YUNG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Following a +1.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where YUNG advanced for three days, in 2 of 3 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The Aroon Indicator entered an Uptrend today. In 12 of 16 cases where YUNG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.